10 Best Stocks to Buy Under $20

3. Roivant Sciences Ltd. (NASDAQ:ROIV)

Share Price as of October 1: $15.75

Number of Hedge Fund Holders: 54

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best stocks to buy under $20. On September 17, Roivant and Priovant Therapeutics announced positive results from the Phase 3 VALOR study, a 52-week placebo-controlled trial evaluating the once-daily oral drug brepocitinib in patients with dermatomyositis/DM. This trial enrolled 241 subjects globally and is noted as the longest and largest interventional DM study ever conducted.

The study met its primary endpoint, with the brepocitinib 30 mg dose achieving a week 52 mean Total Improvement Score/TIS of 46.5, compared to 31.2 for placebo. A statistically significant difference in mean TIS between the 30 mg dose and placebo was observed as early as week 4 and was sustained throughout the one-year study.

This result marks the first-ever positive outcome for a 52-week placebo-controlled trial and the first positive registrational trial for a targeted therapy in DM. Brepocitinib 30 mg also demonstrated clinically meaningful and statistically significant improvement over placebo on all nine key secondary endpoints, which included measurements of skin disease/CDASI, muscle disease/MMT-8, steroid-sparing effect, and rapidity of onset.

Roivant Sciences Ltd. (NASDAQ:ROIV) is a clinical-stage biopharmaceutical company that discovers, develops, and commercializes medicines and technologies.